Molecules
US12017979B2 · kind B2 · utility
0Cited by
8References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2023 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | May 14, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G65/3348
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to TLR2 agonist compounds and their compositions, and the use of such compounds and compositions in the prevention and/or treatment of respiratory infections, or diseases or conditions associated with viral or bacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.